An Australian company called Peplin Inc., which originally filed to come public in August 2007, has filed with the SEC to withdraw its IPO paperwork.  The emerging biotech was going to carry the "PLIN" ticker on NASDAQ.  For those who know much on the international markets, this one trades under the ticker "PEP" in Australia.

The company is requesting such withdrawal because of unfavorable market conditions that would adversely affect the offering of the securities under the Registration Statement and its decision to pursue other financing alternatives.

You can join our open email distribution list to hear about other developments in IPO’s, secondary financings, spin-offs, mergers, and other special situations.

Jon C. Ogg
June 9, 2008